TY - JOUR T1 - Chemotherapy and non-small-cell lung cancer JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 9 LP - 11 DO - 10.1136/dtb.2002.4029 VL - 40 IS - 2 A2 - , Y1 - 2002/02/01 UR - http://dtb.bmj.com/content/40/2/9.abstract N2 - Relevant BNF section: 8.1Around 34,000 people in the UK die from lung cancer each year.1 Over 75% of patients with the disease have non-small-cell lung cancer (NSCLC). Here, we discuss the role of chemotherapy in the management of NSCLC, a treatment that some medical oncologists estimate would benefit 50% of patients with NSCLC,2 but which is given to fewer than 10%.3 ER -